Summer Programs aimed at addressing issues of STEM representation prove to be beneficial for UMass Chan Medical School and the interns involved.  

UMass Chan Medical School and QurAlis Corporation, a clinical-stage biotechnology company investigating treatments for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative and neurological diseases, have formed a collaboration to investigate an antisense oligonucleotide technology for the potential treatment of fragile X syndrome.  

The Robert W. Finberg Physician-Scientist Training Program is named in honor of the late Robert W. Finberg, MD, chair emeritus and distinguished professor of medicine.  

College students enrolled in the Summer Enrichment Program highlight their educational goals and what they have learned from guest speakers, making connections with peers and research projects.  

UMass Chan Medical School and pharmaceutical company Astellas Pharma Inc. have entered into a sponsored research agreement to proceed with research for an adeno-associated virus vector mediated gene therapy for the treatment of Alexander disease, a fatal, ultra-rare disease.

The year-end celebration highlighted the 22 students enrolled in Postbaccalaureate Research Education Program and the Initiative for Maximizing Student Development program who completed major milestones.  

Medical student Akanksha Nagarkar is teaching high school students the impact of food on health through a nonprofit organization she launched in 2018 called M.E.A.L. (My Education, Action and Lifestyle) Inc.  

A study presented by UMass Chan researchers found that roughly one-third of pregnant patients with or at risk for hypertensive disorders reported food insecurity. The authors say the findings support other research suggesting more food support could lead to improved maternal and fetal health.

Benjamin Botsford, MD, assistant professor of ophthalmology & visual sciences, in an article written for The Conversation, explains that despite popular claims, there is no strong scientific evidence that eye exercises can eliminate the need for glasses.

UMass Chan Medical School has received $2.2 million from a nonprofit patient-advocacy organization to contract with Andelyn Biosciences to manufacture clinical grade AAV9-CSA vector to treat Cockayne syndrome.